Research progress of intradialysis hypotension in hemodialysis patients

doi:10.3877/cma.j.issn.2095-3216.2022.03.011

Abstract

Abstract:

Intradialysis hypotension (IDH) is one of the common complications of maintenance hemodialysis (MHD), and its incidence remains high, affecting the quality of life and long-term prognosis of patients. Therefore, it is necessary to avoid IDH risks. In recent years, with the deepening of pathophysiological research, rapid progress has been made in the optimization of prevention and treatment of IDH, such as biofeedback technology, cold dialysis, and traditional Chinese medicine therapy. This article reviewed the latest progress in the definition, harm, pathophysiology, and prevention and treatment strategies of IDH, aiming to provide information and reference for the prevention and treatment of IDH.

Key words: Hemodialysis, Intradialytic hypotension, Physiopathology

Jie Yang, Hongye Wang, Rui Zhang. Research progress of intradialysis hypotension in hemodialysis patients[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2022, 11(03): 172-175.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2022.03.011

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2022/V11/I03/172

Figures/Tables 1

References 36

[1]	Kuipers J, Verboom LM, Ipema KJR, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with meta-analysis [J]. Am J Nephrol, 2019, 49(6): 497-506.
[2]	Kooman J, Basci A, Pizzarelli F, et al. EBPG guideline on haemodynamic instability [J]. Nephrol Dial Transplant, 2007, 22(Suppl 2): ii22-ii44.
[3]	K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients [J]. Am J Kidney Dis, 2005, 45(4 Suppl 3): S1-S153.
[4]	Kim KY, Park HS, Kim JS, et al. Comparison of intradialytic blood pressure metrics as predictors of all-cause mortality [J]. Clin Kidney J, 2021, 14(12): 2600-2605.
[5]	Yu J, Liu Z, Shen B, et al. Intradialytic hypotension as an independent risk factor for long-term mortality in maintaining hemodialysis patients: a 5-year follow-up cohort study [J]. Blood Purif, 2018, 45(4): 320-326.
[6]	Chang TI, Paik J, Greene T, et al. Intradialytic hypotension and vascular access thrombosis [J]. J Am Soc Nephrol, 2011, 22(8): 1526-1533.
[7]	Mc Causland FR, Tumlin JA, Roy-Chaudhury P, et al. Intradialytic hypotension and cardiac arrhythmias in patients undergoing maintenance hemodialysis: results from the monitoring in dialysis study [J]. Clin J Am Soc Nephrol, 2020, 15(6): 805-812.
[8]	Cedeño S, Desco M, Aleman Y, et al. Intradialytic hypotension and relationship with cognitive function and brain morphometry [J]. Clin Kidney J, 2020, 14(4): 1156-1164.
[9]	Jansen MA, Hart AA, Korevaar JC, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients [J]. Kidney Int, 2002, 62(3): 1046-1053.
[10]	Burton JO, Jefferies HJ, Selby NM, et al. Hemodialysis-induced cardiac injury: determinants and associated outcomes [J]. Clin J Am Soc Nephrol, 2009, 4(5): 914-920.
[11]	Yu J, Chen X, Li Y, et al. High ultrafiltration rate induced intradialytic hypotension is a predictor for cardiac remodeling: a 5-year cohort study [J]. Ren Fail, 2021, 43(1): 40-48.
[12]	Macedo E, Karl B, Lee E, et al. A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients [J]. Crit Care, 2021, 25(1): 18.
[13]	Mc Causland FR, Claggett B, Sabbisetti VS, et al. Hypertonic mannitol for the prevention of intradialytic hypotension: a randomized controlled trial [J]. Am J Kidney Dis, 2019, 74(4): 483-490.
[14]	Aronoff GR. The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotension [J]. Semin Dial, 2017, 30(6): 489-491.
[15]	Ettema EM, Zittema D, Kuipers J, et al. Dialysis hypotension: a role for inadequate increase in arginine vasopressin levels? A systematic literature review and meta-analysis [J]. Am J Nephrol, 2014, 39(2): 100-109.
[16]	Marshall MR, Vandal AC, de Zoysa JR, et al. Effect of low-sodium versus conventional sodium dialysate on left ventricular mass in home and self-care satellite facility hemodialysis patients: a randomized clinical trial [J]. J Am Soc Nephrol, 2020, 31(5): 1078-1091.
[17]	Gabutti L, Bianchi G, Soldini D, et al. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids [J]. Nephrol Dial Transplant, 2009, 24(3): 973-981.
[18]	Mustafa RA, Bdair F, Akl EA, et al. Effect of lowering the dialysate temperature in chronic hemodialysis: a systematic review and meta-analysis [J]. Clin J Am Soc Nephrol, 2016, 11(3): 442-457.
[19]	Yoowannakul S, Kotecha T, Fontana M, et al. Do pre-hemodialysis estimates of extracellular volume excess using bioimpedance and N-terminal brain natriuretic peptide correlate with cardiac chamber size measured by magnetic resonance imaging? [J]. Ther Apher Dial, 2019, 23(4): 362-368.
[20]	Jelicic I. Relationship of a food intake during hemodialysis and symptomatic intradialytic hypotension [J]. Hemodial Int, 2021, Epub ahead of print.
[21]	Kim TW, Chang TI, Kim TH, et al. Association of ultrafiltration rate with mortality in incident hemodialysis patients [J]. Nephron, 2018, 139(1): 13-22.
[22]	Leung KCW, Quinn RR, Ravani P, et al. Randomized crossover trial of blood volume monitoring-guided ultrafiltration biofeedback to reduce intradialytic hypotensive episodes with hemodialysis [J]. Clin J Am Soc Nephrol, 2017, 12(11): 1831-1840.
[23]	Dasgupta I, Thomas GN, Clarke J, et al. Associations between hemodialysis facility practices to manage fluid volume and intradialytic hypotension and patient outcomes [J]. Clin J Am Soc Nephrol, 2019, 14(3): 385-393.
[24]	Brunelli SM, Sibbel S, Do TP, et al. Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study [J]. Am J Kidney Dis, 2015, 66(4): 655-665.
[25]	Bullen A, Rifkin D, Trzebinska D. Individualized cool dialysate as an effective therapy for intradialytic hypotension and hemodialysis patients′ perception [J]. Ther Apher Dial, 2019, 23(2): 145-152.
[26]	Maheshwari V, Lau T, Samavedham L, et al. Effect of cool vs warm dialysate on toxin removal: rationale and study design [J]. BMC Nephrol, 2015, 16: 25.
[27]	Locatelli F, Altieri P, Andrulli S, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD [J]. J Am Soc Nephrol, 2010, 21(10): 1798-1807.
[28]	林玲，彭梅，罗凯，等. 参麦注射液对血液透析相关性低血压患者血压、血清白蛋白及透析充分性的影响[J]. 河北中医，2019, 41(5): 706-709.
[29]	于晓瑜，陆丹. 针灸并用预防血液透析相关性低血压的疗效观察[J]. 中国中西医结合肾病杂志，2018, 19(4): 347-348.
[30]	Rhee SY, Song JK, Hong SC, et al. Intradialytic exercise improves physical function and reduces intradialytic hypotension and depression in hemodialysis patients [J]. Korean J Intern Med, 2019, 34(3): 588-598.
[31]	Frankenfield DL, Weinhandl ED, Powers CA, et al. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D [J]. Am J Kidney Dis, 2012, 59(5): 670-681.
[32]	Roberts MA, Pilmore HL, Ierino FL, et al. The β-blocker to lower cardiovascular dialysis events (BLOCADE) feasibility study: a randomized controlled trial [J]. Am J Kidney Dis, 2016, 67(6): 902-911.
[33]	Assimon MM, Brookhart MA, Fine JP, et al. A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis [J]. Am J Kidney Dis, 2018, 72(3): 337-348.
[34]	Brunelli SM, Cohen DE, Marlowe G, et al. The impact of midodrine on outcomes in patients with intradialytic hypotension [J]. Am J Nephrol, 2018, 48(5): 381-388.
[35]	Razeghi E, Dashti-Khavidaki S, Nassiri S, et al. A randomized crossover clinical trial of sertraline for intradialytic hypotension [J]. Iran J Kidney Dis, 2015, 9(4): 323-330.
[36]	Imai E, Fujii M, Kohno Y, et al. Adenosine A1 receptor antagonist improves intradialytic hypotension [J]. Kidney Int, 2006, 69(5): 877-883.

Please choose a citation manager

Content to export